Riskpilot← Back to searchSign inGet full accessMandoc AB
ABActiveOrg 5593797979Fogdevägen 5 A 1103General medical practice activities · NACE 8621Est. 20220 employees
Revenue 2025
SEK 109K
-94% vs 2024
EBITDA margin
63.9%
-89% vs 2024
Equity ratio
51.2%
Financial strength
Net profit 2025
SEK 116K
-72% vs 2024
| Revenue | SEK 109K | -94% |
| EBITDA | SEK 70K | -89% |
| Net profit | SEK 116K | -72% |
| Total assets | SEK 1,2M | -28% |
| Equity | SEK 604K | -28% |
| Employees | 0 | — |
Legal name
Mandoc AB
Org number
5593797979
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 maj 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva hälso- och sjukvård, friskvård, utbildning, konsultverksamhet och handel med friskvårds- och sjukvårdsartiklar, samt därmed förenlig verksamhet. Företaget kommer även bedriva handel med värdepapper.
Address
Fogdevägen 5 A 1103
Email
qais.mangal@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 758 | 758 | 2 131 | 1 733 | 109 |
| Staff expenses | — | −200 | — | — | −25 |
| EBITDA | 478 | 478 | 1 076 | 621 | 70 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 478 | 478 | 1 076 | 621 | 70 |
| Net financials | — | 0 | 5 | 46 | 64 |
| Profit before tax | 359 | 359 | 817 | 516 | 134 |
| Tax | −74 | 74 | −169 | −102 | −18 |
| Net profit | 285 | 285 | 648 | 414 | 116 |
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 756 | 756 | 1 530 | 1 643 | 1 179 |
| Equity | 310 | 310 | 774 | 838 | 604 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 327 | 327 | 372 | 271 | 41 |
| Total debt | 327 | 327 | 372 | 271 | 41 |
EBITDA margin
63.9%
This company
15.8%
Market median
+304% vs market
20222025
Equity ratio
51.2%
This company
38.2%
Market median
+34% vs market
20222025
Return on equity
19.1%
This company
18.4%
Market median
+4% vs market
20222025
Net profit margin
105.6%
This company
8.1%
Market median
+1204% vs market
20222025
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20222025
Debt / equity
0.95×
This company
0.62×
Market median
+53% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-05-10 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-05-01 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mandoc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Roiai Zazai | Deputy Board Member | 0 companies |
| Qais Mangal | Board of Directors | 0 companies |